Screening of Generalized Anxiety Disorder in Patients with Epilepsy: Using a Valid and Reliable Indonesian Version of Generalized Anxiety Disorder-7 (GAD-7)

Table 3

Subjects’ medical characteristics (n=146).

Medical Characteristics	n (%) / Median (min-max)
Onset of Epilepsy (year)	17.5 (1-74)
Duration of Epilepsy (year)	11 (0.5-55)
Seizure Frequency (times)	1 (0-52)
Seizure Type
Focal Onset	143 (97.9)
Generalized Onset	3 (2.1)
Epileptic focality from EEG
Right	61 (41.8)
Left	60 (41.1)
Focal Bilateral	15 (10.3)
General	3 (2.1)
No data	7 (4.8)
Epilepsy Syndrome (n=139)
Temporal	96 (65.8)
Extratemporal	40 (27.4)
Generalized	3 (2.1)
No data	7 (4.8)
AED Administered
1 AED	95 (65.1)
2 AED	40 (27.4)
≥ 3 AED	11 (7.5)
Etiology of Epilepsy
Genetic	3 (2.1)
Unknown Etiology	63 (43.2)
Structural	80 (54.7)
(i) Hippocampal atrophy/sclerosis	37 (46.3)
(ii) Other Structural Abnormalities	43 (53.7)
Type of AED
Valproate	42 (28.8%)
Carbamazepine	46 (31.5%)
Levetiracetam	10 (6.8%)
Phenytoin	43 (29.5%)
Clobazam	31 (21.2%)
Phenobarbital	31 (21.2%)
Clonazepam	1 (0.7%)
Lamictal	1 (0.7%)
Topiramate	2 (1.4%)